BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 35916583)

  • 1. Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes.
    Meister MT; Groot Koerkamp MJA; de Souza T; Breunis WB; Frazer-Mendelewska E; Brok M; DeMartino J; Manders F; Calandrini C; Kerstens HHD; Janse A; Dolman MEM; Eising S; Langenberg KPS; van Tuil M; Knops RRG; van Scheltinga ST; Hiemcke-Jiwa LS; Flucke U; Merks JHM; van Noesel MM; Tops BBJ; Hehir-Kwa JY; Kemmeren P; Molenaar JJ; van de Wetering M; van Boxtel R; Drost J; Holstege FCP
    EMBO Mol Med; 2022 Oct; 14(10):e16001. PubMed ID: 35916583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusion-negative rhabdomyosarcoma 3D organoids to predict effective drug combinations: A proof-of-concept on cell death inducers.
    Savary C; Luciana L; Huchedé P; Tourbez A; Coquet C; Broustal M; Lopez Gonzalez A; Deligne C; Diot T; Naret O; Costa M; Meynard N; Barbet V; Müller K; Tonon L; Gadot N; Degletagne C; Attignon V; Léon S; Vanbelle C; Bomane A; Rochet I; Mournetas V; Oliveira L; Rinaudo P; Bergeron C; Dutour A; Cordier-Bussat M; Roch A; Brandenberg N; El Zein S; Watson S; Orbach D; Delattre O; Dijoud F; Corradini N; Picard C; Maucort-Boulch D; Le Grand M; Pasquier E; Blay JY; Castets M; Broutier L
    Cell Rep Med; 2023 Dec; 4(12):101339. PubMed ID: 38118405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhabdomyosarcoma xenotransplants in zebrafish embryos.
    Siebert J; Schneider M; Reuter-Schmitt D; Würtemberger J; Neubüser A; Driever W; Hettmer S; Kapp FG
    Pediatr Blood Cancer; 2023 Jan; 70(1):e30053. PubMed ID: 36317680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Spindle cell rhabdomyosarcoma in adults: a new entity in the spectrum of malignant mesenchymal tumors of soft tissues].
    Mentzel T
    Pathologe; 2010 Mar; 31(2):91-6. PubMed ID: 19997735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orbital rhabdomyosarcomas and related tumors in childhood: relationship of morphology to prognosis--an Intergroup Rhabdomyosarcoma study.
    Kodet R; Newton WA; Hamoudi AB; Asmar L; Wharam MD; Maurer HM
    Med Pediatr Oncol; 1997 Jul; 29(1):51-60. PubMed ID: 9142207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathological classification of childhood rhabdomyosarcomas: relationship with clinical parameters and prognosis.
    Wijnaendts LC; van der Linden JC; van Unnik AJ; Delemarre JF; Voute PA; Meijer CJ
    Hum Pathol; 1994 Sep; 25(9):900-7. PubMed ID: 8088765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient use of patient-derived organoids as a preclinical model for gynecologic tumors.
    Maru Y; Tanaka N; Itami M; Hippo Y
    Gynecol Oncol; 2019 Jul; 154(1):189-198. PubMed ID: 31101504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathological study of 145 childhood rhabdomyosarcoma cases].
    He LJ; Wang L; Sun N; Huang CR; Zhu XD; Lang ZQ
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):225-8. PubMed ID: 15256113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhabdomyosarcoma: From Obscurity to Clarity in Diagnosis … But With Ongoing Challenges in Management: The Farber-Landing Lecture of 2020.
    Parham DM; Giannikopoulos P
    Pediatr Dev Pathol; 2021; 24(2):87-95. PubMed ID: 33439112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Immunohistochemistry in Rhabdomyosarcoma Diagnosis Using Tissue Microarray Technology and a Xenograft Model.
    Machado I; Mayordomo-Aranda E; Giner F; Llombart-Bosch A
    Fetal Pediatr Pathol; 2015; 34(5):271-81. PubMed ID: 26125949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathology of childhood and adolescent rhabdomyosarcoma].
    Leuschner I; Harms D
    Pathologe; 1999 Mar; 20(2):87-97. PubMed ID: 10320996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 and mdm-2 expression in Rhabdomyosarcoma of childhood and adolescence: clinicopathologic study by the Kiel Pediatric Tumor Registry and the German Cooperative Soft Tissue Sarcoma Study.
    Leuschner I; Langhans I; Schmitz R; Harms D; Mattke A; Treuner J;
    Pediatr Dev Pathol; 2003; 6(2):128-36. PubMed ID: 12574910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood rhabdomyosarcoma with anaplastic (pleomorphic) features. A report of the Intergroup Rhabdomyosarcoma Study.
    Kodet R; Newton WA; Hamoudi AB; Asmar L; Jacobs DL; Maurer HM
    Am J Surg Pathol; 1993 May; 17(5):443-53. PubMed ID: 8470759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental origins of fusion-negative rhabdomyosarcomas.
    Kikuchi K; Rubin BP; Keller C
    Curr Top Dev Biol; 2011; 96():33-56. PubMed ID: 21621066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
    Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
    Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
    [No Abstract]   [Full Text] [Related]  

  • 16. Uterine rhabdomyosarcoma in adults.
    Pinto A; Kahn RM; Rosenberg AE; Slomovitz B; Quick CM; Whisman MK; Huang M
    Hum Pathol; 2018 Apr; 74():122-128. PubMed ID: 29320751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Characterization, Current Model Systems and Prognostic Stratification in PAX Fusion-Negative vs. PAX Fusion-Positive Rhabdomyosarcoma.
    Dehner CA; Armstrong AE; Yohe M; Shern JF; Hirbe AC
    Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric soft tissue sarcomas.
    Loeb DM; Thornton K; Shokek O
    Surg Clin North Am; 2008 Jun; 88(3):615-27, vii. PubMed ID: 18514702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic analysis and preclinical xenograft model development identify potential therapeutic targets for MYOD1-mutant soft-tissue sarcoma of childhood.
    Ting MA; Reuther J; Chandramohan R; Voicu H; Gandhi I; Liu M; Cortes-Santiago N; Foster JH; Hicks J; Nuchtern J; Scollon S; Plon SE; Chintagumpala M; Rainusso N; Roy A; Parsons DW
    J Pathol; 2021 Sep; 255(1):52-61. PubMed ID: 34086347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic features of 300 rhabdomyosarcomas with emphasis upon differential expression of skeletal muscle specific markers in the various subtypes: A single institutional experience.
    Rekhi B; Gupta C; Chinnaswamy G; Qureshi S; Vora T; Khanna N; Laskar S
    Ann Diagn Pathol; 2018 Oct; 36():50-60. PubMed ID: 30098515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.